WallStreetZenWallStreetZen

NASDAQ: TRML
Tourmaline Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TRML earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$42.1M
Current Profit Margin
0%

TRML Return on Equity

Current Company
-25.6%
Current Industry
-63.5%
Current Market
188%
TRML's Return on Equity (-25.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TRML announces earnings.

TRML Return on Assets

Current Company
-24.3%
Current Industry
2.9%
TRML is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TRML Return on Capital Employed

Current Company
-20.52%
Current Industry
19.5%
TRML's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TRML vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TRML$0.00-$41.97M-$42.12MN/AN/A
CBUS$1.82M-$244.57M-$267.63M+50.41%N/A
MRSN$36.86M-$163.30M-$171.67M+28.32%N/A
MREO$10.00M-$27.34M-$29.47M-53.16%N/A
ITOS$12.60M-$108.13M-$112.64M-80.89%N/A
View Top Biotech Stocks

TRML earnings dates

Next earnings date
May 13, 2024

Tourmaline Bio Earnings & Revenue FAQ

What were TRML's earnings last quarter?

On Invalid Date, Tourmaline Bio (NASDAQ: TRML) reported Q4 2023 earnings per share (EPS) of $1.61, up 117.87% year over year. Total Tourmaline Bio earnings for the quarter were $2.13 million. In the same quarter last year, Tourmaline Bio's earnings per share (EPS) was -$9.01.

If you're new to stock investing, here's how to buy Tourmaline Bio stock.

What was TRML's earnings growth in the past year?

As of Q2 2024, Tourmaline Bio's earnings has grown year over year. Tourmaline Bio's earnings in the past year totalled -$42.12 million.

What is TRML's earnings date?

Tourmaline Bio's earnings date is Invalid Date. Add TRML to your watchlist to be reminded of TRML's next earnings announcement.

What was TRML's revenue last quarter?

On Invalid Date, Tourmaline Bio (NASDAQ: TRML) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Tourmaline Bio's revenue was $0.00.

What was TRML's revenue growth in the past year?

As of Q2 2024, Tourmaline Bio's revenue has grown null year over year. Tourmaline Bio's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.